An overview of the pharmacokinetics and promising biological activities for cancer therapy in both humans and animals. Oral Fenbendazole for Cancer Therapy .
The drug interferes with tubulin polymerization, a process essential for cancer cell division. Fenbendazole.org intersect.rar
However, the primary research paper often cited by that community regarding the drug's potential anti-cancer mechanisms is: An overview of the pharmacokinetics and promising biological
The American Cancer Society and other health authorities emphasize that while laboratory studies exist, Fenbendazole is not FDA-approved for human use, and large-scale clinical trials are still needed to confirm its safety and efficacy in people. However, the primary research paper often cited by
If you are looking for specific types of data, these recent publications are frequently referenced:
It promotes the activation of the p53 tumor suppressor protein, leading to programmed cell death (apoptosis). Other Notable Papers
It may block glucose uptake in cancer cells by downregulating GLUT transporters , effectively "starving" the tumor.